Search clinical trials for: Sphingosine 1 Phosphate Receptor Modulators
Total 7596 results
-
Bristol-Myers SquibbActive, not recruitingMultiple SclerosisUnited States
-
Genuine Research Center, EgyptHikma Pharmaceuticals LLCCompleted
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Patient-Centered Outcomes Research Institute; Universita degli Studi di GenovaTerminatedRelapsing Remitting Multiple SclerosisItaly
-
Novartis PharmaceuticalsWithdrawn
-
Novartis PharmaceuticalsCompletedMultiple Sclerosis | Relapsing Multiple Sclerosis | Advancing Multiple SclerosisUnited States, Puerto Rico
-
Novartis PharmaceuticalsCompletedRelapsing Multiple SclerosisUnited States
-
General Hospital of Shenyang Military RegionRecruiting
-
CelgeneCompletedMultiple SclerosisUnited States, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Germany, Greece, Hungary, Italy, Latvia, Lithuania, Moldova, Republic of, New Zealand, Poland, Portugal, Romania, Serbia, Slovakia, South... and more
-
Novartis PharmaceuticalsCompletedSTudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START) (START)Multiple SclerosisGermany
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
CelgeneCompleted
-
University Hospital MuensterNovartisUnknownRelapsing Remitting Multiple SclerosisGermany
-
Bristol-Myers SquibbRecruiting
-
Second Affiliated Hospital, School of Medicine,...Shaoxing People's Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital and other collaboratorsRecruitingStroke | InflammationChina
-
NovartisCompletedEfficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (FREEDOMS)Relapsing-remitting Multiple SclerosisCanada, Australia, Israel, Belgium, Czech Republic, Finland, France, Germany, Greece, Lithuania, Netherlands, Poland, Russian Federation, Slovakia, South Africa, Sweden, Switzerland, Turkey, United Kingdom
-
Bristol-Myers SquibbRecruitingRelapsing Multiple SclerosisChina
-
Novartis PharmaceuticalsTerminatedAcute Demylelinating Optic NeuritisUnited States, Spain
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Centre de Recherche de l'Institut Universitaire...Bristol-Myers Squibb; CelgeneTerminated
-
Mayo ClinicNational Cancer Institute (NCI)CompletedPain | Chemotherapy-Induced Peripheral Neuropathy | Numbness | TinglingUnited States
-
Universitätsklinikum Hamburg-EppendorfUnknown
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
The Methodist Hospital Research InstituteEnrolling by invitationKidney Failure, Chronic | Kidney Transplant Rejection | Graft Rejection | Kidney Transplant; Complications | Kidney Transplant Failure | Kidney Transplant Failure and Rejection | Interstitial FibrosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisUnited Kingdom
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
CelgeneNot yet recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Wake Forest University Health SciencesActive, not recruitingStroke Hemorrhagic | Intracerebral Hemorrhage | Cerebral Edema | Intracerebral Hemorrhage, Hypertensive | Intracerebral Hemorrhage IntraparenchymalUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple Sclerosis (RMS)China
-
Mayo ClinicNational Cancer Institute (NCI)CompletedBreast CarcinomaUnited States
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
ActelionCompleted
-
Indiana UniversityCompleted
-
Asofarma S.A.I. y C.Zenith Technology Corporation LimitedCompletedHealthy VolunteersNew Zealand
-
Novartis PharmaceuticalsCompleted
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
Novartis PharmaceuticalsCompletedRenal Transplantation
-
Novartis PharmaceuticalsMitsubishi Tanabe Pharma CorporationCompletedRenal Transplantation
-
CelgeneCompletedHealthy VolunteersUnited States
-
NovartisCompletedRelapsing Multiple SclerosisBelgium, Poland, Spain, France, United Kingdom, Guatemala, Canada, Finland, Switzerland
-
Charite University, Berlin, GermanyNeuroCure Clinical Research Center, Charite, BerlinTerminatedMOdification of VIsual Outcomes After Optic Neuritis in CIS or MS by Gilenya (MOVING Study) (MOVING)Multiple SclerosisGermany
-
Bristol-Myers SquibbNot yet recruitingUlcerative ColitisUnited States
-
CelgeneCompletedHealthy VolunteersUnited States
-
Isfahan University of Medical SciencesShiraz University of Medical SciencesCompleted
-
Novartis PharmaceuticalsCompletedHemorrhagic Stroke | Intracerebral Hemorrhage (ICH)United States